Tel：+86-18874232226 WhatsApp：+86-18874232226 E-mail：lisa@qankorey.com
Qankorey was invited to attend the Alzheimer's disease academic conference held by PURELAB on May 22, 2025, the largest testing center in the Middle East
Visits:
2025-05-23
Hunan Qankorey Biotechnology Co., Ltd is honored to have been invited to participate in the industry expert exchange and academic conference "Advancing Lab Diagnostics in Alzheimer's & Dementia" held by PURELAB on May 22, 2025, the largest testing center in the Middle East. Meanwhile, renowned medical institutions and health insurance companies such as Roche Pharmaceuticals, Daman, and SEHA also attended the conference to jointly discuss the prevention and diagnosis of Alzheimer's disease.
The product director, Dr. June Zhu, shared and introduced the company's self-developed the world's first patented product-One Step Dementia Risk Test Kit (Colloidal Gold Lateral Immunochromatography), this kit is urine risk screening reagent for Alzheimer's disease – A Breakthrough in Preventive Diagnostics and brings a brand-new experience to home self-testing. During the conference, academic experts and the Gan Kang team had in-depth exchanges, and answered all the questions raised by the teachers in detail. This is not only a technological breakthrough but also a milestone in human memory health.
The Chief Medical Officer of PURELAB, Carlor, highly praised the test strip for Aβ detection in urine developed by Qankorey, hoping to quickly launch cooperation between the two sides to jointly serve the health of people in the Middle East.
Through years of unremitting efforts, the scientific research team of Qankorey Technology has exclusively developed a highly specific Aβ monoclonal antibody, which can accurately identify and bind to Aβ in urine. Through a clever original design of the antibody-polymer sandwich technology, the presence and content changes of Aβ are converted into intuitive detection signals, so as to effectively assess the risk of AD.
This product is used for in vitro qualitative detection of β-amyloid concentration in human urine. It only requires 4 drops of urine, no medical equipment or professional personnel are needed for operation, and the result can be quickly visually read in 10 minutes. It has the characteristics of earlier detection, more convenience, faster speed, higher effectiveness, and greater popularity, making it very suitable for use in home or community environments. Its unique design allows users to perform self-testing at any time and any place, which greatly improves the convenience and coverage of screening.
PURELAB as a trusted healthcare ally, showcases an impressive suite of over 1,200 in-house tests across 150+ laboratories, 3 centers of excellence, and 6 other specialised ones throughout the UAE. 50+ noteworthy accreditations, including our ASHI-accredited HLA lab and AABB-accredited blood bank, highlight our exceptional standards in quality and precision. Our team of over 1000 clinicians always meets test turnaround times (TAT) with a competent success rate and successfully conducts over 25 million tests annually.
Thanks for all support, listening and sharing, it’s a success event. All contributions have turned this event into a meaningful platform for education, collaboration, and advocacy.
Previous: No more!
RELATED INFORMATION
2025/04/16
Domestic business consulting Tel:+86-731-85714218
E-mail:qankorey@qankorey.com
Internation Marketing Tel:+86-18874232226
E-mail:lisa@qankorey.com
Company address: 12F, Building 15, No.188 Middle Huanbao Road, Yuhua District, Changsha, Hunan, China 410116
Production Address: 4/F, Building 7, Yuhua Intelligent Manufacturing Center, No.2 Hongda Road, Tongsheng Street, Yuhua District, Changsha,Hunan China,410007
Public Number
Small program
Jingdong
Taobao